0M0F.L - Tandem Diabetes Care, Inc.
| Previous close | 24.64 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 1,691 |
| Market cap | 14.147M |
| Beta (5Y monthly) | 0.97 |
| PE ratio (TTM) | 2.81 |
| EPS (TTM) | 0.09 |
| Earnings date | 01 Aug 2023 - 07 Aug 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Motley FoolGot $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond.
These stocks have moved in opposite directions lately, but both could deliver solid returns to patient investors.
ZacksHere's Why You Should Retain Tandem Diabetes (TNDM) Now
Investors continue to be optimistic about Tandem Diabetes (TNDM) based on the strong performance of the t:slim X2 insulin pump.
Business WireTandem Diabetes Care to Present at the Jefferies Healthcare Conference
SAN DIEGO, May 24, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the Jefferies Healthcare Conference on Thursday, June 8, 2023 at 1:30pm Eastern Time (10:30am Pacific Time).
ZacksTandem Diabetes (TNDM) Q1 Earnings Miss, Gross Margin Dips
According to Tandem Diabetes (TNDM), Q1 revenues are in line with the high end of its expectations.
ZacksTandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Lags Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of -12.50% and 1.29%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireTandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance
SAN DIEGO, May 03, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2023 and reaffirmed its financial guidance for the year ending December 31, 2023.
ZacksWill KORU Medical Systems Inc. (KRMD) Report Negative Earnings Next Week? What You Should Know
KORU Medical Systems Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksEarnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline
Tandem Diabetes Care, Inc. (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business WireTandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference
SAN DIEGO, April 20, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the BofA Securities 2023 Health Care Conference on Wednesday, May 10, 2023 at 4:40pm Eastern Time (1:40pm Pacific Time).
Business WireTandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes
SAN DIEGO, April 17, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by Diabetes Technology & Therapeutics of a meta-analysis of three randomized controlled trials of its Control-IQ advanced hybrid closed-loop technology. Results demonstrate the positive clinical impact of the system’s automatic correction bolusing on glucose control across a wide range of ages and demographics of people living with type 1 d
Business WireTandem Diabetes Care to Announce First Quarter 2023 Financial Results on May 3, 2023
SAN DIEGO, April 11, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2023 results after the financial markets close on Wednesday, May 3, 2023. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2023 financial and operating results.
ZacksWhy Is Masimo (MASI) Up 0.2% Since Last Earnings Report?
Masimo (MASI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksTandem Diabetes (TNDM) Releases Favorable Data on t:slim X2
Tandem Diabetes (TNDM) demonstrated positive results from the clinical trial of advancing its Control-IQ technology to younger age group patients.
Business WireTandem Diabetes Care Announces NEJM Publication of Study Demonstrating Increased Time in Range in Young Children with Type 1 Diabetes Using the t:slim X2 Insulin Pump with Control-IQ Technology
SAN DIEGO, March 15, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication of results from the Pediatric Artificial Pancreas (PEDAP) Clinical Trial by the New England Journal of Medicine showing an approximate 3-hour per day increase in time in range* in children ages 2-5 years old using the t:slim X2 insulin pump with Control-IQ advanced hybrid closed-loop technology** compared to those on a standard insulin pump
Motley FoolThis Stock Could Soar By as Much as 106%, According to Wall Street
Some of Wall Street's predictions seem a bit aggressive, but investors should still consider this company.
ZacksTandem Diabetes (TNDM) Q4 Earnings Beat, Gross Margin Dips
Tandem Diabetes (TNDM) Q4 GAAP sales reflect an accounting deferral related to the recent introduction of the company's Tandem Choice program in the United States.
ZacksTandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Misses Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of 50% and 1.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Business WireTandem Diabetes Care Appoints New Chair of Board of Directors
SAN DIEGO, February 22, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Rebecca Robertson as Chair of its Board of Directors. Ms. Robertson, who joined Tandem’s Board as an independent director in January 2019, succeeds Kim Blickenstaff, who will continue as a member of the Board.
Business WireTandem Diabetes Care Announces Fourth Quarter 2022 Financial Results and Full Year 2023 Financial Guidance
SAN DIEGO, February 22, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2022 and provided its financial guidance for the year ending December 31, 2023.
Business WireTandem Diabetes Care Announces Upcoming Conference Presentations
SAN DIEGO, February 15, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:
Motley Fool2 Growth Stocks to Buy While They Are Still Down
With that in mind, let's look at two growth stocks that fit the bill: Tandem Diabetes Care (NASDAQ: TNDM) and Fiverr (NYSE: FVRR). Medical device specialist Tandem Diabetes Care focuses on the diabetes market, as its name suggests. The company has been an innovator in the field, and right now, it makes money by selling its prized insulin pump, the t:slim X2.
Business WireTandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical
SAN DIEGO, January 23, 2023--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced the completion of its previously announced acquisition of AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump. The Sigi Patch Pump, designed to be an ergonomic, rechargeable patch pump that reduces the burden of managing diabetes through its use of pre-filled insulin cartridges, is under development and not commercially available
Business WireTandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
SAN DIEGO, January 19, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2022 results after the financial markets close on Wednesday, February 22, 2023. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2022 financial and operating results.
Business WireTandem Diabetes Care Reports Preliminary, Unaudited 2022 Sales and Reaffirms 2023 Outlook
SAN DIEGO, January 10, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its preliminary, unaudited sales for the fourth quarter and year ended December 31, 2022 and worldwide sales outlook for the year ending December 31, 2023.
Business WireTandem Diabetes Care to Present at the 41st Annual J.P. Morgan Healthcare Conference
SAN DIEGO, January 03, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 8:15pm Eastern Time (5:15pm Pacific Time).
